Apadamtase alfa Recruiting Phase 3 Trials for Congenital Thrombotic Thrombocytopenic Purpura Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04683003A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura